TokenPost topic

RAP-219

1 TokenPost story is tagged RAP-219. The newest appear first.

Latest RAP-219 stories

• Rapport Therapeutics' RAP-219 Meets Phase 2 Goals in Bipolar Mania Trial

  RAP-219 showed a 3.1-point advantage on a mania rating scale after three weeks, but 24.6% of recipients stopped treatment early.

  Oct 20, 2026, 1:52 PM EDT · Business